The Role of IRE1 Signaling in the Central Nervous System Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|16|9|1340-1347

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.16, Iss.9, 2018-11, pp. : 1340-1347

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabotropic Glutamate Receptors in Central Nervous System Diseases

By  

Current Drug Targets, Vol. 17, Iss. 5, 2016-04 ,pp. : 538-616

Bentham Science Publishers

Access to resources Recommend Favorite

Thiazolidine: A Potent Candidate for Central Nervous System Diseases

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 17, Iss. 1, 2017-02 ,pp. : 26-29

Bentham Science Publishers

Access to resources Recommend Favorite

Recent progress in the use of glycine transporter-1 inhibitors for the treatment of central and peripheral nervous system diseases

By Slassi Abdelmalik   Egle Ian  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 2, 2004-02 ,pp. : 201-214

Informa Healthcare

Access to resources Recommend Favorite

Metabolic Signaling to the Central Nervous System: Routes Across the Blood Brain Barrier

By  

Current Pharmaceutical Design, Vol. 20, Iss. 9, 2014-03 ,pp. : 1392-1399

Bentham Science Publishers

Access to resources Recommend Favorite

Notch Signaling in the Central Nervous System with Special Reference to its Expression in Microglia

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 6, 2013-01 ,pp. : 807-814

Bentham Science Publishers

Access to resources Recommend Favorite